These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 31929371)
1. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses. Zhang YM; Zhou XJ; Shi SF; Liu LJ; Lyu JC; Zhang H Chin Med J (Engl); 2020 Feb; 133(3):277-284. PubMed ID: 31929371 [TBL] [Abstract][Full Text] [Related]
2. Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy. Li Z; Han Q; Ye H; Li J; Wei X; Zhang R; Huang Q; Xu Y; Liu G; Li B; Yang Q BMC Nephrol; 2022 Feb; 23(1):78. PubMed ID: 35196994 [TBL] [Abstract][Full Text] [Related]
3. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849 [TBL] [Abstract][Full Text] [Related]
5. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358 [TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy. Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165 [TBL] [Abstract][Full Text] [Related]
9. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience. Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052 [TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S; Yang X; Luo J; Guo H Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045 [TBL] [Abstract][Full Text] [Related]
11. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients. Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871 [TBL] [Abstract][Full Text] [Related]
12. Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study. Xia M; Liu D; Peng L; Li Y; Liu H; Wu L; Chen G; Liu Y; Liu H BMC Nephrol; 2020 Oct; 21(1):447. PubMed ID: 33109129 [TBL] [Abstract][Full Text] [Related]
13. The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study. Lee HS; In S; Park T Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371949 [TBL] [Abstract][Full Text] [Related]
14. Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome. Huang N; Li J; Ai Z; Guo L; Chen W; Liu Q Int Urol Nephrol; 2024 Sep; 56(9):3003-3011. PubMed ID: 38564075 [TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190 [TBL] [Abstract][Full Text] [Related]
16. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity. Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344 [TBL] [Abstract][Full Text] [Related]
17. Causal relationship between Jing S; Lin L; Li J; Pan J; Qiao X Ren Fail; 2024 Dec; 46(2):2371055. PubMed ID: 38946159 [TBL] [Abstract][Full Text] [Related]
18. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131 [TBL] [Abstract][Full Text] [Related]
19. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease. Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969 [TBL] [Abstract][Full Text] [Related]
20. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation. Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D Nutrients; 2023 May; 15(10):. PubMed ID: 37242290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]